Skip to main content
. 2014 Jun 10;2014(6):CD006744. doi: 10.1002/14651858.CD006744.pub3
Study Reason for exclusion
Joo 2008 Tamsulosin versus no treatment for TWOC in spinal surgery patients electively catheterised perioperatively (not in acute urinary retention prior to surgery).
Kraus 2010 No catheters involved. Urodynamic assessment of daily tadalafil versus placebo on lower urinary tract symptoms.
Lim 1999 No alpha blockers used in study. Study describes outcome of TWOC in 79 untreated patients.
Liu 2009 No catheters involved as patients not in acute urinary retention. Randomised trial of amlodipine with or without terazosin for LUTS.
Lorente 2004 Use of increasing dosage of doxazosin in failed TWOC patients. 40 patients randomly assigned to doxazosin 4 mg once daily (n = 20) or no treatment (n = 20) for seven days before TWOC. Failed TWOC patients either received doxazosin 8mg (treatment group) or 4 mg (control group) once daily before a second TWOC.
Martov 2010 No catheters involved as study assessing tamsulosin for stent‐related irritative symptoms.
McNeill 2004 Long‐term follow‐up study of patient cohort who had successful TWOC following an episode of acute urinary retention (alfuzosin versus placebo).
Taube 1989b No alpha‐blockers used in study. Study describes outcome of TWOC immediately, after 24 and 48 hours in 60 untreated patients (subdivided into three groups).
Wang 2009 No catheters involved as study assessing effect of tamsulosin in patients with indwelling double‐J ureteral stents.

LUTS = lower urinary tract symptoms
 TWOC = trial without catheter